Published in J Exp Med on February 02, 1998
Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. Proc Natl Acad Sci U S A (1999) 1.56
Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J Exp Med (2004) 1.22
Eosinophil survival and apoptosis in health and disease. Allergy Asthma Immunol Res (2010) 0.97
Human eosinophils release IL-1ß and increase expression of IL-17A in activated CD4+ T lymphocytes. Clin Exp Allergy (2012) 0.94
Curcumin suppresses ovalbumin-induced allergic conjunctivitis. Mol Vis (2012) 0.84
Regulation of spontaneous eosinophil apoptosis-a neglected area of importance. J Cell Death (2014) 0.83
Mitochondria in the center of human eosinophil apoptosis and survival. Int J Mol Sci (2014) 0.82
Nitric oxide-induced eosinophil apoptosis is dependent on mitochondrial permeability transition (mPT), JNK and oxidative stress: apoptosis is preceded but not mediated by early mPT-dependent JNK activation. Respir Res (2012) 0.82
Essential roles of PKA, iNOS, CD95/CD95L, and terminal caspases in suppression of eosinopoiesis by PGE2 and other cAMP-elevating agents. ScientificWorldJournal (2013) 0.80
Distinct effects of ceramide-generating pathways in prostate adenocarcinoma cells. Br J Pharmacol (1999) 0.77
Increase of nitrosative stress in patients with eosinophilic pneumonia. Respir Res (2011) 0.75
Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (1988) 18.41
JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell (1994) 16.30
Apoptosis by death factor. Cell (1997) 14.42
The L-arginine-nitric oxide pathway. N Engl J Med (1993) 14.38
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell (1996) 12.07
Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med (1995) 10.91
Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell (1996) 9.93
Eosinophilic inflammation in asthma. N Engl J Med (1990) 8.05
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J (1995) 7.60
Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther (1981) 6.71
Protease activation during apoptosis: death by a thousand cuts? Cell (1995) 5.15
Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (1996) 4.92
Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature (1996) 3.37
Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J (1993) 3.29
Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93
Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci U S A (1995) 2.89
Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med (1994) 2.71
Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med (1994) 2.47
Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res (1990) 2.40
Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science (1996) 2.31
FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity (1995) 2.19
cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci U S A (1996) 2.17
Kinase suppressor of Ras is ceramide-activated protein kinase. Cell (1997) 2.05
Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity (1997) 2.04
Nitric oxide and asthmatic inflammation. Immunol Today (1995) 2.01
T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol (1991) 1.98
Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase. J Cell Biol (1994) 1.96
Sorting out the cytokines of asthma. J Exp Med (1996) 1.92
Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res (1994) 1.90
Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol (1994) 1.89
Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Immunol Today (1995) 1.66
Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci U S A (1995) 1.62
Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol (1992) 1.56
Protein degradation as an index of oxidative stress. Methods Enzymol (1990) 1.51
Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood (1991) 1.51
Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J Immunol (1995) 1.46
APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur J Immunol (1993) 1.39
Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood (1997) 1.37
CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene (1996) 1.33
Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood (1995) 1.30
JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur J Immunol (1996) 1.27
Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol (1994) 1.27
Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med (1996) 1.24
Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc Natl Acad Sci U S A (1994) 1.19
Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol (1997) 1.17
Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med (1996) 1.08
Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol (1997) 1.07
IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol (1995) 1.02
Eosinophils transcribe and translate messenger RNA for inducible nitric oxide synthase. J Immunol (1997) 1.00
Expression and function of the Fas receptor on human blood and tissue eosinophils. Eur J Immunol (1996) 0.98
Nitric oxide-mediated suppression of T cell responses during Trypanosoma brucei infection: soluble trypanosome products and interferon-gamma are synergistic inducers of nitric oxide synthase. Eur J Immunol (1996) 0.97
Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J Clin Invest (1995) 0.96
Regulation of the Fas apoptotic cell death pathway by Abl. J Biol Chem (1995) 0.96
The reaction of azide with catalase and their significance. Biochem J (1964) 0.94
Fas-mediated apoptosis in cultured human eosinophils. Blood (1996) 0.94
Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma. J Immunol (1994) 0.93
The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Am J Respir Crit Care Med (1995) 0.91
Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways. Hepatology (1995) 0.89
Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med (1999) 6.04
Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proc Natl Acad Sci U S A (1986) 5.12
Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent. Proc Natl Acad Sci U S A (1976) 3.74
A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes. J Virol (1987) 3.58
Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. Am J Respir Crit Care Med (1994) 3.13
An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods (1991) 2.96
Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis (1992) 2.89
Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ (2009) 2.89
Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells. J Exp Med (1988) 2.80
Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol (2001) 2.62
Role of interleukin 10 in specific immunotherapy. J Clin Invest (1998) 2.57
Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology (1987) 2.53
The Caenorhabditis elegans autosomal dominant polycystic kidney disease gene homologs lov-1 and pkd-2 act in the same pathway. Curr Biol (2001) 2.27
Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature (2001) 2.01
T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol (1991) 1.98
Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol (1991) 1.92
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91
SAPALDIA: methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in Adults. Soz Praventivmed (1997) 1.88
T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest (2000) 1.85
Mechanisms of interleukin-10-mediated immune suppression. Immunology (2001) 1.70
Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma. Allergy (1997) 1.69
Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Immunol Today (1995) 1.66
Prediction of readmissions after CABG using detailed follow-up data: the Israeli CABG Study (ISCAB) Med Care (1999) 1.62
NMR structure of the calreticulin P-domain. Proc Natl Acad Sci U S A (2001) 1.58
Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. Proc Natl Acad Sci U S A (1999) 1.56
Thermophoresis of DNA determined by microfluidic fluorescence. Eur Phys J E Soft Matter (2004) 1.54
Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol (1998) 1.52
Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med (1995) 1.47
In vitro differentiation of near-unlimited numbers of functional mouse basophils using conditional Hoxb8. Allergy (2013) 1.43
Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet (1997) 1.43
Intracellular localization of the BCL-2 family member BOK and functional implications. Cell Death Differ (2013) 1.40
Levels of soluble interleukin-2 receptor-alpha are elevated in serum and ascitic fluid from epithelial ovarian cancer patients. Am J Obstet Gynecol (1994) 1.40
Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration. Eur J Immunol (1992) 1.33
IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur J Immunol (2000) 1.30
Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol (1991) 1.30
Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest (1996) 1.29
Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA- memory T cells. J Immunol (1997) 1.27
Display of expression products of cDNA libraries on phage surfaces. A versatile screening system for selective isolation of genes by specific gene-product/ligand interaction. Eur J Biochem (1994) 1.25
Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med (1996) 1.24
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC). Ann Oncol (2005) 1.23
Thermodiffusion of charged colloids: single-particle diffusion. Langmuir (2007) 1.22
Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) with IgE binding and type I skin test activity. J Immunol (1992) 1.19
Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc Natl Acad Sci U S A (1994) 1.19
Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol (1997) 1.17
A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J (2000) 1.16
Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus. J Exp Med (1996) 1.14
No correlation of focal contacts and close adhesion by comparing GFP-vinculin and fluorescence interference of Dil. Eur Biophys J (2001) 1.14
Absence of HLA association or linkage for variations in sensitivity to the odor of androstenone. Immunogenetics (1982) 1.14
IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J (1999) 1.13
[15N,1H]/[13C,1H]-TROSY for simultaneous detection of backbone 15N-1H, aromatic 13C-1H and side-chain 15N-1H2 correlations in large proteins. J Biomol NMR (2000) 1.13
Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy (2000) 1.12
Sequence-specific NMR assignment of proteins by global fragment mapping with the program MAPPER. J Biomol NMR (2000) 1.12
Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J Immunol (1999) 1.11
Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore. Eur J Immunol (1993) 1.11
Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A). Cell Death Differ (2007) 1.09
Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med (1996) 1.08
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1. FASEB J (2001) 1.08
A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5. Blood (1996) 1.07
Purified recombinant A. fumigatus allergens induce different responses in mice. Clin Immunol (2001) 1.06
Humoral and cell-mediated autoimmune reactions to human acidic ribosomal P2 protein in individuals sensitized to Aspergillus fumigatus P2 protein. J Exp Med (1999) 1.06
Extracellular DNA traps in allergic, infectious, and autoimmune diseases. Allergy (2013) 1.06
Induction and function of eosinophil intercellular adhesion molecule-1 and HLA-DR. J Immunol (1992) 1.05
Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy (2001) 1.04
Cytomegalovirus infection and common variable immunodeficiency. Lancet (1992) 1.04
Lambda2 light chains in normal mouse immunoglobulins. Proc Natl Acad Sci U S A (1978) 1.03
Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int Immunol (1998) 1.03
Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood (1998) 1.02
IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol (1995) 1.02
CD137 activation abrogates granulocyte-macrophage colony-stimulating factor-mediated anti-apoptosis in neutrophils. Eur J Immunol (2000) 1.01
Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin. Ann Oncol (2005) 1.01
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX. Ann Oncol (2011) 1.00
T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2. J Immunol (1993) 1.00
Cloning Aspergillus fumigatus allergens by the pJuFo filamentous phage display system. Int Arch Allergy Immunol (1996) 1.00
Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction. Clin Res Cardiol (2007) 0.99
Effects of C-reactive protein on lymphocyte functions. III. Inhibition of antigen-induced lymphocyte stimulation and lymphokine production. Cell Immunol (1977) 0.99
Induction of Bim limits cytokine-mediated prolonged survival of neutrophils. Cell Death Differ (2009) 0.99
Immune regulation in atopic dermatitis. Curr Opin Immunol (2000) 0.99
Prognostic criteria for dogs with oral melanoma. J Am Vet Med Assoc (1981) 0.99
Allergens of Aspergillus fumigatus and Candida boidinii share IgE-binding epitopes. Am J Respir Crit Care Med (1997) 0.99
Suppression of the benzylpenicilloyl- (BPO) specific IgE formation with isologous anti-idiotypic antibodies in BALB/c mice. J Immunol (1980) 0.98
Hearing smiles and frowns in normal and whisper registers. J Acoust Soc Am (1994) 0.98
T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies. J Immunol (2000) 0.98
Exciton transfer dynamics and quantumness of energy transfer in the Fenna-Matthews-Olson complex. Phys Rev E Stat Nonlin Soft Matter Phys (2011) 0.98
Expression and function of the Fas receptor on human blood and tissue eosinophils. Eur J Immunol (1996) 0.98